Barometer Capital Management’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
– Sell
-4,700
Closed -$617K – 137
2022
Q4
$617K Buy
+4,700
New +$607K 0.18% 80
2016
Q1
– Sell
-3,000
Closed -$338K – 169
2015
Q4
$338K Sell
3,000
-1,800
-38% -$195K 0.03% 112
2015
Q3
$485K Sell
4,800
-9,540
-67% -$1.14M 0.06% 104
2015
Q2
$1.76M Buy
14,340
+4,740
+49% +$567K 0.14% 85
2015
Q1
$1.1M Buy
9,600
+3,900
+68% +$430K 0.09% 99
2014
Q4
$576K Sell
5,700
-7,500
-57% -$729K 0.05% 109
2014
Q3
$1.2M Buy
13,200
+6,300
+91% +$553K 0.1% 79
2014
Q2
$591K Sell
6,900
-1,500
-18% -$118K 0.11% 84
2014
Q1
$661K Buy
+8,400
New +$700K 0.14% 79

Other funds holding IBB

Barometer Capital Management's IBB Position: Q1 2023 in Review

Barometer Capital Management sold out of iShares Biotechnology ETF (IBB) in Q1 2023, closing a stake of 4,700 shares — an estimated $617K sold.

Barometer Capital Management first reported a position in IBB in Q1 2014 and held it in 9 quarters. The position peaked at $1.76M in Q2 2015. 866 funds tracked by Wall St. Rank hold IBB as of Q1 2023.

  • Barometer Capital Management reported no remaining iShares Biotechnology ETF position as of Q1 2023 after selling out during the quarter.
  • Barometer Capital Management sold 4,700 iShares Biotechnology ETF shares in Q1 2023, an estimated $617K.
  • Barometer Capital Management first reported a position in iShares Biotechnology ETF in Q1 2014 and held it in 9 quarters.
  • Barometer Capital Management's iShares Biotechnology ETF position peaked at $1.76M in Q2 2015.
  • 866 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2023.

Based on Barometer Capital Management's 13F filing for Q1 2023, filed 11 May 2023.